Category: Germ Control
FDA Approves Jaypirca for Untreated CLL and SLL
The FDA approves Jaypirca for previously untreated CLL and SLL without del(17p), showing improved outcomes...
New treatments for myelofibrosis and anemia emerge
New treatments for myelofibrosis and anemia may improve symptoms and quality of life for patients.
US hospitals top global oncology rankings
US hospitals rank high in global oncology rankings, with Memorial Sloan Kettering in first place,...
New dual-imaging catheter assesses heart attack risk in humans
New dual-imaging catheter assesses heart attack risk by detecting plaque buildup in arteries, potentially improving...
Younger women face breast cancer diagnosis delays, study finds
Young women face breast cancer diagnosis delays, with lower income linked to later-stage disease, highlighting...
Safety prompts cut risky AI choices in clinical tests
Safety prompts can cut risky AI choices in clinical tests, as researchers found that brief...
Algae Study Leads to 2026 Nobel for Optogenetics
The 2026 Nobel Prize in physiology or medicine honors three scientists for an algae study...
Navy reports suicide attempts aboard extended Lincoln carrier deployment
The USS Abraham Lincoln carrier strike group reported eight suicide attempts during a 10-month deployment,...
Expert Discusses TDP-43 Role in ALS Research
Expert discusses TDP-43 role in ALS research, a protein present in 97% of ALS patients,...
Oveporexton Shows Symptom Improvement in Narcolepsy Type 1%
Oveporexton shows symptom improvement in narcolepsy type 1, improving wakefulness and quality of life.